Search by Drug Name or NDC

    NDC 63868-0316-24 Migraine Relief 250; 250; 65 mg/1; mg/1; mg/1 Details

    Migraine Relief 250; 250; 65 mg/1; mg/1; mg/1

    Migraine Relief is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by CHAIN DRUG MARKETING ASSOCIATION INC. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.

    Product Information

    NDC 63868-0316
    Product ID 63868-316_ee299f62-f505-5e30-e053-2995a90a3c41
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Migraine Relief
    Proprietary Name Suffix n/a
    Non-Proprietary Name ACETAMINOPHEN, ASPIRIN and CAFFEINE
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 250; 250; 65
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; ASPIRIN; CAFFEINE
    Labeler Name CHAIN DRUG MARKETING ASSOCIATION INC
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA214039
    Listing Certified Through 2024-12-31

    Package

    NDC 63868-0316-24 (63868031624)

    NDC Package Code 63868-316-24
    Billing NDC 63868031624
    Package 1 BOTTLE, PLASTIC in 1 CARTON (63868-316-24) / 24 TABLET in 1 BOTTLE, PLASTIC
    Marketing Start Date 2022-05-05
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 4ec0f9e7-a533-4084-a03a-24c25132435a Details

    Revised: 11/2022